Gary S. Mezo
PIONEERING, REVOLUTIONARY & INNOVATIVE. Founder, Chairman/CEO & Medical Director of NanoBiotech Pharma, Inc. Inventor of a novel class of therapeutics: Nanobiotics. Our published science, clinical trials & in-house research is well-established. We now conduct research with prominent researchers at highly-respected institutions. Current/past collaborators: Mayo clinic, Cleveland clinic, Baylor, NASA, UCSD, Stanford and literally, scores more. Invented of NanobacTX, the first Nanobiotic that targets the pathological calcification, inflammation & amyloid deposition of Nanobacteria infection & associated vascular & systemic health issues. Nanobacteria ( also known as CNPs or NPs) are linked to the development of atherosclerosis, calcified atherosclerotic plaque, pathological calcification, inflammation & coronary artery disease. Invented Urobac, the second Nanobiotic that targets CNPs, inflammation, plaque & calcification in the urogenital tract (BPH, Chronic Prostatitis, PKD & Kidney Stones). More Nanobiotics are in the pipeline. Our most recent research is in Vascular Dementia & Alzheimer's Disease with clinical trials planned. Two popular books have been written about my R&D: "Has Heart Disease Been Cured" and "The Calcium Bomb" and featured in medical book chapters and medical research. Have been the subject of Fox TV News Reports and conduct lectures to physicians and other health providers. Family Practice & Emergency Medicine 28 years - now retired from seeing patients, now Medical Researcher & Serial entrepreneur.